Evaluation of Gastric Insufflation Measured by Ultrasound of the Antral Surface During Optiflow Preoxygenation

Gastric Ultrasound Clinical Trial

Official title:

Evaluation of Gastric Insufflation Measured by Ultrasound of the Antral Surface During Optiflow Preoxygenation

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04206111
• Other study ID #: Optisafe
• Status: Recruiting
• Start date: June 1, 2020
• Est. completion date: October 1, 2020

Study information

• Verified date: June 2020
• Source: University of Liege
• Contact: Benjamin Javillier, MD
• Phone: 003243667180
• Email: benjamin.javillier[@]chuliege.be
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Check in gastric ultrasound for lack of stomach insufflation during preoxygenation with high-flow nasal cannulas

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: October 1, 2020
• Est. primary completion date: September 1, 2020
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adults Volunteers

Exclusion Criteria:

• History of gastric surgery

• Facial or oropharyngeal abnormality

Related Conditions & MeSH terms

• Gastric Ultrasound

Intervention

Procedure:
• Preoxygenation
preoxygenation with high flow nasal cannula at 40l/min for 5min

Locations

Country	Name	City	State
Belgium	Javillier	Liège

Sponsors (1)

Lead Sponsor	Collaborator
University of Liege

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	no gastric insufflation	Number of Participants with no gastric insufflation	From date of randomization until the date of first documented progression, whichever came first, assessed up to 6 months